Skip to main content
Top
Published in: Diabetologia 3/2020

Open Access 01-03-2020 | Prediabetes | Article

A pragmatic and scalable strategy using mobile technology to promote sustained lifestyle changes to prevent type 2 diabetes in India and the UK: a randomised controlled trial

Authors: Arun Nanditha, Hazel Thomson, Priscilla Susairaj, Weerachai Srivanichakorn, Nick Oliver, Ian F. Godsland, Azeem Majeed, Ara Darzi, Krishnamoorthy Satheesh, Mary Simon, Arun Raghavan, Ramachandran Vinitha, Chamukuttan Snehalatha, Kate Westgate, Soren Brage, Stephen J. Sharp, Nicholas J. Wareham, Desmond G. Johnston, Ambady Ramachandran

Published in: Diabetologia | Issue 3/2020

Login to get access

Abstract

Aims/hypothesis

This randomised controlled trial was performed in India and the UK in people with prediabetes to study whether mobile phone short message service (SMS) text messages can be used to motivate and educate people to follow lifestyle modifications, to prevent type 2 diabetes.

Methods

The study was performed in people with prediabetes (n = 2062; control: n = 1031; intervention: n = 1031) defined by HbA1c ≥42 and ≤47 mmol/mol (≥6.0% and ≤6.4%). Participants were recruited from public and private sector organisations in India (men and women aged 35–55 years) and by the National Health Service (NHS) Health Checks programme in the UK (aged 40–74 years without pre-existing diabetes, cardiovascular disease or kidney disease). Allocation to the study groups was performed using a computer-generated sequence (1:1) in India and by stratified randomisation in permuted blocks in the UK. Investigators in both countries remained blinded throughout the study period. All participants received advice on a healthy lifestyle at baseline. The intervention group in addition received supportive text messages using mobile phone SMS messages 2–3 times per week. Participants were assessed at baseline and at 6, 12 and 24 months. The primary outcome was conversion to type 2 diabetes and secondary outcomes included anthropometry, biochemistry, dietary and physical activity changes, blood pressure and quality of life.

Results

At the 2 year follow-up (n = 2062; control: n = 1031; intervention: n = 1031), in the intention-to-treat population the HR for development of type 2 diabetes calculated using a discrete-time proportional hazards model was 0.89 (95% CI 0.74, 1.07; p = 0.22). There were no significant differences in the secondary outcomes.

Conclusions/interpretation

This trial in two countries with varied ethnic and cultural backgrounds showed no significant reduction in the progression to diabetes in 2 years by lifestyle modification using SMS messaging.

Trial registration

The primary study was registered on www.​ClinicalTrials.​gov (India, NCT01570946; UK, NCT01795833).

Funding

The study was funded jointly by the Indian Council for Medical Research and the UK Medical Research Council.
Literature
2.
go back to reference Ramachandran A, Snehalatha C, Shetty SA, Nanditha A (2014) Global health perspectives in prediabetes and diabetes prevention. In: Bergman M (ed) Primary prevention trials in type 2 diabetes. World Scientific Publishing, Singapore, pp 49–74 Ramachandran A, Snehalatha C, Shetty SA, Nanditha A (2014) Global health perspectives in prediabetes and diabetes prevention. In: Bergman M (ed) Primary prevention trials in type 2 diabetes. World Scientific Publishing, Singapore, pp 49–74
8.
go back to reference Shetty AS, Chamukuttan S, Nanditha A, Raj RK, Ramachandran A (2011) Reinforcement of adherence to prescription recommendations in Asian Indian diabetes patients using short message service (SMS)—a pilot study. J Assoc Physicians India 59:711–714PubMed Shetty AS, Chamukuttan S, Nanditha A, Raj RK, Ramachandran A (2011) Reinforcement of adherence to prescription recommendations in Asian Indian diabetes patients using short message service (SMS)—a pilot study. J Assoc Physicians India 59:711–714PubMed
12.
go back to reference Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Diabetes Res Clin Pract 93:299–309 Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Diabetes Res Clin Pract 93:299–309
18.
go back to reference Madden JP, Goodman SJ, Guthrie HA (1976) Validity of the 24-hr. recall. Analysis of data obtained from elderly subjects. J Am Diet Assoc 68(2):143–147PubMed Madden JP, Goodman SJ, Guthrie HA (1976) Validity of the 24-hr. recall. Analysis of data obtained from elderly subjects. J Am Diet Assoc 68(2):143–147PubMed
23.
go back to reference Prentice RL, Gloeckler LA (1978) Regression analysis of grouped survival data with application to breast cancer data. Biometrics 34(1):57–67CrossRefPubMed Prentice RL, Gloeckler LA (1978) Regression analysis of grouped survival data with application to breast cancer data. Biometrics 34(1):57–67CrossRefPubMed
30.
Metadata
Title
A pragmatic and scalable strategy using mobile technology to promote sustained lifestyle changes to prevent type 2 diabetes in India and the UK: a randomised controlled trial
Authors
Arun Nanditha
Hazel Thomson
Priscilla Susairaj
Weerachai Srivanichakorn
Nick Oliver
Ian F. Godsland
Azeem Majeed
Ara Darzi
Krishnamoorthy Satheesh
Mary Simon
Arun Raghavan
Ramachandran Vinitha
Chamukuttan Snehalatha
Kate Westgate
Soren Brage
Stephen J. Sharp
Nicholas J. Wareham
Desmond G. Johnston
Ambady Ramachandran
Publication date
01-03-2020
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 3/2020
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-019-05061-y

Other articles of this Issue 3/2020

Diabetologia 3/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.